122 related articles for article (PubMed ID: 3511982)
1. The detection of specific antibody formation to recall antigens after human bone marrow transplantation.
Lum LG; Munn NA; Schanfield MS; Storb R
Blood; 1986 Mar; 67(3):582-7. PubMed ID: 3511982
[TBL] [Abstract][Full Text] [Related]
2. Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.
Lum LG; Noges JE; Beatty P; Martin PJ; Deeg J; Doney KC; Loughran T; Sullivan KM; Witherspoon RP; Thomas ED
Bone Marrow Transplant; 1988 Sep; 3(5):399-406. PubMed ID: 3056548
[TBL] [Abstract][Full Text] [Related]
3. Adoptively transferred immunity persists in human marrow graft recipients.
Lum LG; Seigneuret MC; Shiobara S; Noges J; Munn N; Shough N; Jin NR; Beatty P; Martin P; Sullivan K
Prog Clin Biol Res; 1987; 244():449-60. PubMed ID: 2821549
[TBL] [Abstract][Full Text] [Related]
4. Kinetic of the antibody titers to tetanus toxoid (TT), diphtheria toxoid (DT), measles virus, poliomyelitis virus and S. pneumoniae after marrow grafting.
Prager J; Baumert A; Gerike E; Böthig B; Kühnemund O; Thilo W; Hermann J; Fuchs D; Zintl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):533-40. PubMed ID: 2480304
[No Abstract] [Full Text] [Related]
5. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
Shiobara S; Lum LG; Witherspoon RP; Storb R
Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
Jin NR; Lum LG
Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
[TBL] [Abstract][Full Text] [Related]
7. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.
Lum LG; Seigneuret MC; Storb R
J Clin Immunol; 1986 Sep; 6(5):389-96. PubMed ID: 2429980
[TBL] [Abstract][Full Text] [Related]
8. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
[TBL] [Abstract][Full Text] [Related]
10. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG.
Janoff EN; Hardy WD; Smith PD; Wahl SM
J Immunol; 1991 Oct; 147(7):2130-5. PubMed ID: 1918947
[TBL] [Abstract][Full Text] [Related]
11. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: effect of conditioning on the specific immune response of the graft recipient.
Labadie J; van Tol MJ; Dijkstra NH; Zwaan FE; Vossen JM
Br J Haematol; 1992 Mar; 80(3):381-90. PubMed ID: 1581219
[TBL] [Abstract][Full Text] [Related]
12. Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria.
Lagergård T; Trollfors B; Claesson BA; Karlberg J; Taranger J
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):341-5. PubMed ID: 1396754
[TBL] [Abstract][Full Text] [Related]
13. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
[TBL] [Abstract][Full Text] [Related]
15. Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs.
Grosse-Wilde H; Krumbacher K; Schüning F; Doxiadis I; Mahmoud HK; Emde C; Schmidt-Weinmar A; Schaefer UW
Transplantation; 1986 Jul; 42(1):64-7. PubMed ID: 3523884
[TBL] [Abstract][Full Text] [Related]
16. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Gerritsen EJ; Van Tol MJ; Van 't Veer MB; Wels JM; Khouw IM; Touw CR; Jol-Van Der Zijde CM; Hermans J; Rümke HC; Radl J
Blood; 1994 Dec; 84(12):4374-82. PubMed ID: 7994052
[TBL] [Abstract][Full Text] [Related]
17. Designed transfer of specific immune responses with bone marrow transplantation.
Saxon A; Mitsuyasu R; Stevens R; Champlin RE; Kimata H; Gale RP
J Clin Invest; 1986 Oct; 78(4):959-67. PubMed ID: 3531239
[TBL] [Abstract][Full Text] [Related]
18. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
Ljungman P; Wiklund-Hammarsten M; Duraj V; Hammarström L; Lönnqvist B; Paulin T; Ringdén O; Pepe MS; Gahrton G
J Infect Dis; 1990 Aug; 162(2):496-500. PubMed ID: 2197342
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy in canine chimeras.
Kolb HJ; Günther W; Schumm M; Holler E; Wilmanns W; Thierfelder S
Transplantation; 1997 Feb; 63(3):430-6. PubMed ID: 9039935
[TBL] [Abstract][Full Text] [Related]
20. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
